Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
about
Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal modelsScatter factor/hepatocyte growth factor in brain tumor growth and angiogenesisHepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer ChallengeMechanisms of evasive resistance to anti-VEGF therapy in glioblastomac-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinomaAn orally bioavailable c-Met kinase inhibitor potently inhibits brain tumor malignancy and growth.MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.Interactions between PTEN and receptor tyrosine kinase pathways and their implications for glioma therapyA novel bispecific c-MET/PD-1 antibody with therapeutic potential in solid cancer.EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts.Experimental approaches for the treatment of malignant gliomas.Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line.An update in the use of antibodies to treat glioblastoma multiforme.The molecular profile of microglia under the influence of glioma.Nuclear phosphorylated Y142 β-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion.HGF-MET cascade, a key target for inhibiting cancer metastasis: the impact of NK4 discovery on cancer biology and therapeutics.Tumor-associated macrophages in glioma: friend or foe?Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF)Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma.A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111).Resolving the phylogenetic origin of glioblastoma via multifocal genomic analysis of pre-treatment and treatment-resistant autopsy specimens.
P2860
Q24629814-81A3BD9D-580C-42A7-80B3-9E8D75539E91Q24683896-49071493-21D7-4168-8160-4B0282637876Q26781273-3A7C2212-CFE4-409D-9514-C75407F66BD2Q27021470-02E367C2-D211-4222-8E7C-8A7F99C4E0A5Q28362076-3C3D886C-AFE0-4A75-B049-22A226EE7B2EQ30428363-08436A6D-1AAC-4D1D-842C-3833969F53ADQ30434616-3D25B93B-E1CF-442F-A5A3-76251EB577EBQ30437740-8BBAE4D3-D63F-44A5-AF85-74686B4B5F8BQ33710008-9E756C13-D0F5-4504-BD94-7E2C6BDE632CQ33756853-214711C3-7D6E-436D-8EBB-977ED41DF8E7Q34127138-CAE487EB-5051-4473-A006-2D6AF5A3E3BFQ34785157-B3A94A15-D88A-4E62-9A22-A944ACC1BCECQ37329927-B80A7299-0EFE-4F84-A694-53C55E862E62Q38008966-BFE4033D-AB0D-4D12-9EDC-AAB2041A8B14Q38812830-63C086B7-13FC-470D-9EB2-7201DD13AC12Q39214964-75246B90-CA9F-47A8-9833-F1932FF9A1B0Q41062315-123903E3-EB1D-4B11-BE10-89159C635F34Q41966511-597A7D97-1899-4B43-8FBF-41BC8AB62821Q47296083-010D9312-5DEE-416B-90F8-2FE125CFD8A5Q51031755-EA204EBA-4B12-4CBD-9B98-F488CB36E935Q55262612-FEF8EF9D-F9A5-4B72-BA5F-E6222D6F1018
P2860
Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Scatter factor/hepatocyte grow ...... owth and angiogenesis in vivo.
@en
Scatter factor/hepatocyte grow ...... owth and angiogenesis in vivo.
@nl
type
label
Scatter factor/hepatocyte grow ...... owth and angiogenesis in vivo.
@en
Scatter factor/hepatocyte grow ...... owth and angiogenesis in vivo.
@nl
prefLabel
Scatter factor/hepatocyte grow ...... owth and angiogenesis in vivo.
@en
Scatter factor/hepatocyte grow ...... owth and angiogenesis in vivo.
@nl
P2093
P1476
Scatter factor/hepatocyte grow ...... owth and angiogenesis in vivo.
@en
P2093
Goldberg ID
Johnston P
P304
P577
1997-04-01T00:00:00Z